Monopar Therapeutics reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Wilmette, IL
SEC filing record 1 source field available
Fiscal year end
31 December
Monopar Therapeutics has filed 513 SEC EDGAR filings since 18 Jun 2015

SEC filing history

Showing 476-500 of 513 matching filings.

Per page
25
Current page
20
UPLOAD

UPLOAD filing

Filing date
03 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-55866

QUARTERLY REPORT

Filing date
09 Nov 2018
Reporting date
30 Sep 2018
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
27 Sep 2018
Reporting date
28 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Sep 2018
Reporting date
09 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Sep 2018
Reporting date
09 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Sep 2018
Reporting date
09 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Sep 2018
Reporting date
09 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Sep 2018
Reporting date
09 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Sep 2018
Reporting date
09 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Sep 2018
Reporting date
28 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-55866

QUARTERLY REPORT

Filing date
09 Aug 2018
Reporting date
30 Jun 2018
Next action
Verify source filing
8-K File 000-55866

PRIMARY DOCUMENT

Filing date
02 Jul 2018
Reporting date
20 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55866

PRIMARY DOCUMENT

Filing date
05 Jun 2018
Reporting date
04 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-55866

PRIMARY DOCUMENT

Filing date
11 May 2018
Reporting date
31 Mar 2018
Next action
Verify source filing
DEF 14C File 000-55866

PRIMARY DOCUMENT

Filing date
20 Apr 2018
Reporting date
04 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-55866

MONOPAR THERAPEUTICS INC.

Filing date
26 Mar 2018
Reporting date
31 Dec 2017
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
09 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-55866

CT ORDER filing

Filing date
09 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
08 Jan 2018
Reporting date
08 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
08 Jan 2018
Reporting date
08 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
08 Jan 2018
Reporting date
08 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
08 Jan 2018
Reporting date
08 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
08 Jan 2018
Reporting date
08 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
08 Jan 2018
Reporting date
08 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
08 Jan 2018
Reporting date
08 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .